Infliximab treatment for symptomatic Crohn's disease strictures

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 3, 2009, Pages 279-285

  Pelletier, A L ^a   Kalisazan, B ^a   Wienckiewicz, J ^a   Bouarioua, N ^a   SoulE J C ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; PREDNISONE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DRUG CONTRAINDICATION; FEMALE; FOLLOW UP; HUMAN; INTESTINE OBSTRUCTION; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; ILEAL DISEASES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58149098618     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03887.x     Document Type: Article

References (31)

1. Beaugerie L, Carat F, Bouvier A, et al. Cohorte nationale CESAME (cancers et sur-risque associé aux maladies inflammatoires chroniques intestinales en France). données démographiques et médicales 2004-2005 pour 20919 patients 2006 30 : A154.
2. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005 54 : 237 41.
3. Louis E, Boverie J, Dewit O, Baert F, De Vos M, D'Haens G. Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study. Acta Gastroenterol Belg 2007 70 : 15 9.
4. Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL, Kleibeuker JH. Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol 2006 18 : 255 61.
5. Vermeire S, van Assche G, Rutgeerts P. Review article: Altering the natural history of Crohn's disease - evidence for and against current therapies. Aliment Pharmacol Ther 2007 25 : 3 12.
6. Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, Falk W. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 1999 45 : 210 7.
7. Graham MF. Pathogenesis of intestinal strictures in Crohn's disease: an update. Inflamm Bowel Dis 1995 1 : 220 7.
8. van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 2004 10 : 55 60.
9. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992 33 : 331 5.
10. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990 99 : 956 63.
11. Hassan C, Zullo A, De Francesco V, et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007 26 : 1457 64.
12. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002 359 : 1541 9.
13. Rutgeerts P, Feagan BG, Lichtenstein GR, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004 126 : 402 13.
14. Treton X, Stefanescu C, Attar A, Alves A, Zappa M, Bouhnik Y. [Ileal stenosis]. Gastroenterol Clin Biol 2007 31 : 387 92.
15. Bernstein CN, Greenberg H, Boult I, Chubey S, Leblanc C, Ryner L. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease. Am J Gastroenterol 2005 100 : 2493 502.
16. Schreyer AG, Golder S, Seitz J, Herfarth H. New diagnostic avenues in inflammatory bowel diseases. Capsule endoscopy, magnetic resonance imaging and virtual enteroscopy. Dig Dis 2003 21 : 129 37.
17. Vasilopoulos S, Kugathasan S, Saeian K, et al. Intestinal strictures complicating initially successful Infliximab treatment for luminal Crohn's disease. Am J Gastroenterol 2000 2503 : A315.
18. Toy LS, Scherl J, Kornbluth A, et al. Complete bowel obstruction following initial response to infliximab therapy for Crohn's disease: a series of newly described complications. Gastroenterology 2000 118 : A569.
19. Lichtenstein GR, Olson A, Travers S, et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease. Am J Gastroenterol 2006 101 : 1030 8.
20. Holtmann MH, Neurath MF. Anti-TNF strategies in stenosing and fistulizing Crohn's disease. Int J Colorectal Dis 2005 20 : 1 8.
21. Marrache F, Gornet JM, Pacault V, et al. Effet de l'infliximab au cours de la maladie de Crohn chez les patients ayant une sténose digestive. Gastroenterol Clin Biol 2005 29 : A188.
22. Geboes K, Dalle I. Influence of treatment on morphological features of mucosal inflammation. Gut 2002 50 (Suppl. 3 III37 42.
23. D'Haens G. Mucosal healing in pediatric Crohn's disease: the goal of medical treatment. Inflamm Bowel Dis 2004 10 : 479 80.
24. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006 63 : 433 42.
25. Colombel JF, Bouhnik Y, Soulé JC, Lerebours E, groupe GETAID. Endoscopic healing of Crohn's ileo-colitis with azathioprine. Gastroenterology 2003 124 : A196.
26. Soulé JC, Etieney I. L'imurel peut-il guérir la maladie deCrohn (MC)? Gastroenterol Clin Biol 2003 27 : A148.
27. Mantzaris JG, Petraki K, Chadio-Lordanides H, et al. Maintenance therapy with azathioprine is superior to budesonide in healing endoscopic lesions and improving histology in clinically quiescent Crohn's disease. Gastroenterology 2008 122 : A81.
28. Landi B, Anh TN, Cortot A, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology 1992 102 : 1647 53.
29. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990 98 : 811 8.
30. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999 116 : 294 300.
31. Rutgeerts P, Vermeire S, van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut 2007 56 : 453 5.